Alzheimer Disease

Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.

Alzheimer disease-or dementia with Lewy bodies? Recently revised consensus criteria can help you solve this diagnostic dilemma.

Although high blood pressure may put patients at risk for dementia, a class of antihypertensives appears to have a preventive effect.

The genetics of dementia, dyslipidemia, and diabetes may hold the key to preventive therapy.

Three recent studies on dementia show antioxidants lack preventive effects, autoimmune disease hospitalization is a risk factor, and cognitive stimulation has modest benefits.

The caffeine in your morning cup of java could pack a neuroprotective punch.

Insights from 3 recent studies on the benefits of mental stimulation for mild cognitive impairment, effect of brain stimulation on memory, and risk of dementia in men with sleep apnea.

Can cardiovascular fitness help older adults ward off dementia?

New research shows it’s not “all in your head”-it’s also in your gut.

Highlights of 3 recent studies that focus on psychiatric disorders in older adults.

The goal of clinically relevant detection of neuropathological hallmarks may be in sight.

The co-occurrence of depression and cognitive impairment doubles every 5 years after the age of 70. Here we present a list of elements in a comprehensive and extended evaluation of depression in the elderly.

“Doctor, will you prescribe medical marijuana for my mother? I think it might help her agitation better than the medication you gave her last visit.”

Older adults seem willing to take a hypothetical predictive test-and plan accordingly.

Three new studies offer insights into psychiatric disorders in the elderly.

For up to 60% of patients with bipolar disorder, simply treating their mood symptoms is not enough to help them return to a full life.

Can't keep up with the literature? Here's some help.

When agitation and psychosis symptoms are severe, is an antipsychotic medication an option? Not always.

The latest research on the global risk of Alzheimer disease and other dementias.

Editors' choices of noteworthy psychiatry stories from around the Web: genetics of schizophrenia, Alzheimer disease, the perils of mixing prescription and over-the-counter medications, new guidelines for treating pain with opioids, and other topics.

Sleep disorders represent a significant problem in patients with Alzheimer disease. Here: assessment strategies and a review of drug and non-drug interventions.

A paradigm-shifting finding holds the potential to alter how we perceive brain-immune interactions for disorders like schizophrenia and Alzheimer disease. It would enable a more mechanistic approach to the study of the neuroimmunology of these and other disorders.

Although delusional jealousy was described as an initial symptom in Alois Alzheimer’s first case report, little is known about its clinical features and prognosis in dementia.

This film is a must-see for psychiatrists, not because it adds new information about the course of Alzheimer disease or its impact on families, but because it forces us to rethink issues that can affect our clinical practice.

The potential of TMS as a treatment for cognitive disorders, fatigue, pain, and other manifestations of brain disease is discussed, as is the encouraging prospect for neuropsychiatric management of many patients.